Merck KGaA May Sell Generics Division
This article was originally published in The Pink Sheet Daily
Company also closes agreement to acquire the majority of capital and voting rights of Swiss drug maker Serono.
You may also be interested in...
Merck acquires family-owned shares representing 64.5% of Serono's capital and will launch a tender offer for the remainder, at a total value of $13.27 bil.
Singapore-based institute is also looking at dengue fever and malaria, exec says in interview with “The Pink Sheet” DAILY.
Lilly will pay up to $500 million to settle the "vast majority" of claims alleging that the company failed to adequately warn patients of risks associated with the atypical antipsychotic Zyprexa (olanzapine), the firm announced Jan. 4